MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 1:05 p.m. Eastern Time. The event will be live-streamed on... Read more
ANDOVER, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that transform our world, today announced that Ram Mayampurath has been appointed Executive Vice President, Chief Financial Officer and Treasurer, effective October 14, 2024. Read more
ANDOVER, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on September 6, 2024, to Read more
ANDOVER, Mass., July 23, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced today that it successfully completed the repricing of its $2.6 billion and €0.8 billion secured tranche B term loans maturing in Read more
The facility will support wafer fabrication equipment production in the region and globally ANDOVER, Mass. and KUALA LUMPUR, Malaysia, June 10, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that it Read more
ANDOVER, Ma., May 16, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”) today announced the closing of its offering of $1.4 billion aggregate principal amount of its 1.25% convertible senior notes due 2030 (the “notes”). The net proceeds from the offering were approximately Read more
ANDOVER, Mass., May 13, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”) today announced the pricing of its offering of $1.2 billion aggregate principal amount of 1.25% convertible senior notes due 2030 (the “notes”). The notes will be offered and sold in a private placement Read more
ANDOVER, Mass., May 13, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”) today announced that it intends to offer, subject to market and other conditions, $1.0 billion aggregate principal amount of convertible senior notes due 2030 (the “notes”) in a private placement (the Read more
ANDOVER, Mass., May 08, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on June 7, 2024, to Read more
ANDOVER, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on March 8, 2024, to Read more